TY - JOUR
T1 - Circulating levels of neurotrophic factors are unchanged in patients with Parkinson’s disease
AU - Rocha, Natalia Pessoa
AU - Ferreira, João Paulo Sampaio
AU - Scalzo, Paula Luciana
AU - Barbosa, Izabela Guimarães
AU - de Souza, Mariana Soares
AU - Christo, Paulo Pereira
AU - Reis, Helton José
AU - Teixeira, Antonio Lucio
N1 - Publisher Copyright:
© 2018, Associacao Arquivos de Neuro-Psiquiatria. All rights reserved.
PY - 2018/5
Y1 - 2018/5
N2 - There is great evidence linking neurotrophic factor (NF) dysfunction with Parkinson’s disease (PD) pathophysiology. This study was conducted to evaluate plasma levels of NFs and their possible associations with clinical symptoms in PD. For this purpose, 40 PD patients and 25 controls were subjected to a clinical evaluation and peripheral blood draw. Plasma levels of brain-derived neurotrophic factor (BDNF), pro-BDNF, neurotrophin 3, neurotrophin 4, nerve growth, glial cell line-derived neurotrophic factor and ciliary neurotrophic factor were measured by enzyme-linked immunosorbent assay. There was no significant difference between PD patients and controls regarding the plasma levels of the evaluated NFs. In addition, NF levels were not associated with disease duration, degree of motor or functional impairment, cognitive performance or severity of depressive symptoms. In conclusion, although NFs may play relevant roles in the pathophysiology of PD, the circulating levels of these molecules are not necessarily changed in patients with PD.
AB - There is great evidence linking neurotrophic factor (NF) dysfunction with Parkinson’s disease (PD) pathophysiology. This study was conducted to evaluate plasma levels of NFs and their possible associations with clinical symptoms in PD. For this purpose, 40 PD patients and 25 controls were subjected to a clinical evaluation and peripheral blood draw. Plasma levels of brain-derived neurotrophic factor (BDNF), pro-BDNF, neurotrophin 3, neurotrophin 4, nerve growth, glial cell line-derived neurotrophic factor and ciliary neurotrophic factor were measured by enzyme-linked immunosorbent assay. There was no significant difference between PD patients and controls regarding the plasma levels of the evaluated NFs. In addition, NF levels were not associated with disease duration, degree of motor or functional impairment, cognitive performance or severity of depressive symptoms. In conclusion, although NFs may play relevant roles in the pathophysiology of PD, the circulating levels of these molecules are not necessarily changed in patients with PD.
KW - Biomarkers
KW - Cognition
KW - Depression
KW - Nerve growth factors
KW - Parkinson’s disease
UR - http://www.scopus.com/inward/record.url?scp=85048226254&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85048226254&partnerID=8YFLogxK
U2 - 10.1590/0004-282x20180035
DO - 10.1590/0004-282x20180035
M3 - Article
C2 - 29898077
AN - SCOPUS:85048226254
SN - 0004-282X
VL - 76
SP - 310
EP - 315
JO - Arquivos de neuro-psiquiatria
JF - Arquivos de neuro-psiquiatria
IS - 5
ER -